Research Article
Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
Table 1
Clinical and para-clinical data of 64 canine mammary tumors hospitalized in veterinary clinics and hospitals in Tehran during 2010–2020.
| Variable | No. | Frequency (%) |
| Age (years) | ≤8 | 23 | 35.94 | 9–11 | 21 | 32.81 | ≥12 | 20 | 31.25 |
| Tumor size (cm) | <3 | 31 | 48.44 | 3.1–4.9 | 26 | 40.62 | ≥5 | 7 | 10.94 |
| Laterality | Right | 28 | 43.75 | Left | 36 | 56.25 |
| Lymph node status | N0 | 50 | 78.12 | N1 | 14 | 21.88 |
| Vascular invasion | Absent | 29 | 45.31 | Present | 35 | 54.69 |
| Perineural invasion | Absent | 51 | 79.69 | Present | 13 | 20.31 |
| Necrosis | Absent | 39 | 60.94 | Present | 25 | 39.06 |
| Type of surgery | Simple mastectomy | 36 | 56.25 | Regional mastectomy | 20 | 31.25 | Radical mastectomy | 8 | 12.5 |
| Histological grade | Grade 1 | 27 | 42.19 | Grade 2 | 25 | 39.06 | Grade 3 | 12 | 18.75 |
| TNM stage | Stage I | 31 | 48.44 | Stage II | 20 | 31.25 | Stage III | 13 | 20.31 |
|
|